Breastmilk, Sars-CoV2
Conditions
Brief summary
The Canadian Paediatric Society recommends breastfeeding during COVID-19 infection. Human milk is the best form of infant nutrition providing significant protection against many illnesses for term and preterm infants. When mothers of hospitalized infants are unable to supply their milk, the recommended supplement is human donor milk. The impact of a pandemic on human milk banking is unknown. This study seeks to address this public health issue. Donor milk will be collected from the Rogers Hixon Ontario Human Milk Bank at Sinai Health System in Toronto. Samples will be analyzed for the COVID-19 virus specific nucleic acid and antibody in real-time and results will be immediately disseminated to relevant organizations to inform local, national and international guidelines surrounding donor milk banking to protect the health of infants.
Interventions
OTHERHuman milk donors
Human milk donors for the Rogers Hixon Ontario Human Milk Bank
Sponsors
University of Toronto
Sinai Health System
Deborah O'Connor
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
Yes
Inclusion criteria
\- Human milk donor for the Rogers Hixon Ontario Human Milk Bank
Exclusion criteria
\- None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of SARS-CoV-2 in breastmilk | 2 months | To describe the prevalence of human milk donations received at the Ontario Human Milk Bank that test positive for SARS-CoV-2 |
| Prevalence of SARS-CoV-2 antibody in breastmilk | 2 months | To describe the prevalence of human milk donations received at the Ontario Human Milk Bank with antibodies for SARS-CoV-2 |
Countries
Canada
Outcome results
None listed